Insider Monkey125d agoneutral
Tempus AI (TEM) Launches Next-Gen Agentic Platform to Accelerate Oncology ResearchNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Exec Edge129d agoneutral
CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty OncologySimply Wall St.129d agoneutral
Does Tempus AI’s (TEM) Rare Cancer Data Push Reveal a Durable Precision Oncology Moat?Stocktwits130d agoneutral
TEM Stock Slips Overnight: CEO-Linked $9.6M Share Sale Puts A Cloud Over 'AI As Physician' StoryInsider Monkey133d agoneutral
Tempus AI (TEM) is Amongst AI stocks Under $30 That Carry High Short InterestInsider Monkey138d agobullish
Is Tempus AI, Inc. (TEM) Among the Best AI Drug Discovery Stocks to Buy According to Hedge Funds?Insider Monkey145d agoneutral
Tempus Al, Inc. (TEM) Opens Open-Source Digital Pathology ConsortiumSimply Wall St.149d agoneutral
Tempus AI (TEM) Stock After 23% Year-To-Date Decline Is Opportunity EmergingInsider Monkey151d agoneutral
Tempus AI (TEM) Is One Of The Best Healthcare Mid-Cap AI Stock According To AnalystsSimply Wall St.156d agoneutral
Assessing Tempus AI (TEM) Valuation After Recent Share Price Rebound And Underpriced Growth NarrativeInsider Monkey159d agobullish
H.C. Wainwright Maintains Buy Rating on Tempus AI (TEM) Following Strong Revenue GrowthSimply Wall St.160d agobullish
Tempus AI (TEM) Is Up 9.3% After New FDA-Cleared CDx And AI Oncology Platform UpgradesSimply Wall St.163d agoneutral
How The Tempus AI (TEM) Investment Story Is Shifting As Analysts Rework Their ModelsSimply Wall St.166d agoneutral
Tempus AI Expands Precision Oncology With New Prostate Test And ASCO DataInsider Monkey168d agoneutral
Tempus AI (TEM) Launches ArteraAI Prostate Test, The First Externally Developed Digital Pathology AlgorithmInsider Monkey170d agobullish
Tempus AI, Inc. (TEM) and Bristol Myers Announce a Strategic PartnershipSimply Wall St.174d agoneutral
Assessing Tempus AI (TEM) Valuation After Recent Share Price WeaknessSimply Wall St.174d agoneutral
Tempus AI And BMS Deepen AI Drug Development Ties As Losses Persist24/7 Wall St.174d agoneutral
7 Healthcare AI Stocks Under $50 With Huge Upside Potential